Equities

IFR US ECM Pricings

 |  Robert Sherwood

BKV (US, energy E&P) ─ $261.7m Block. 9.7m shares (Primary, Secondary) at $27.00 versus $27.00-$28.00 marketing and $28.94 last sale. RBC. Bedrock Energy Partners is the selling shareholder.

CRISPR Therapeutics (Switzerland, biotech) ─ $550m 5y cvt priced at 1.125%, up 45% versus 0.75%-1.25% and 35%-40% marketing. JEFF, JPM. Upsized from $350m.

Diamondback Energy (US, energy E&P) ─ $1.9bn ABB. 11m shares (Secondary) at $172.25 versus $172.25-$176.00 marketing and $178.37 last sale. EVER, CITI, JPM. Wall cross. Autry Stephens estate is the selling shareholder.

Dianthus Therapeutics (US, biotech) ─ $629.9m FO. 7.8m shares (Primary) at $81.00 versus $86.92 last sale and $79.23 at launch. JEFF, TDC, EVER, STFL, GUGG, WBLR. Upsized from $400m. Includes pre-funded warrants.

Kosmos Energy (US, energy E&P) ─ $185.3m ABB. 97.5m shares (Primary) at $1.90 versus $1.90-$2.20 marketing and $2.41 last sale. BARC, STFL. 

Pague Menos (Brazil, pharmacy chain) ─ R$458.5m (US$89m) FO. 70m shares (Primary, Secondary) at R$6.55 versus R$6.55 last sale and R$6.82 at launch. BTG, ITAU, XP, BRAD, SANT. Queiros family is the selling shareholder.

Xenon Pharmaceuticals (Canada, biotech) ─ $650m FO. 11.4m shares (Primary) at $57.00 versus $60.61 last sale and $62.76 at launch. JPM, JEFF, TDC, STFL, RBC, WBLR. Upsized from $500m. Includes pre-funded warrants.

Topics
Americas North America Asia / Pacific East Asia Japan Equity Capital Marketed Follow-Ons United States Structured Equity Initial Public Offerings (IPO) Canada US Dollar ABBs and Block Trades South America Brazil
Issuers
Empreendimentos Pague Menos SA (PGMN3.SA) CRISPR Therapeutics AG (CRSP.BN) Dianthus Therapeutics Inc (DNTH.O) Xenon Pharmaceuticals Inc (XENE.O) BKV Corp (BKV.N) Diamondback Energy Inc (FANG.O) Kosmos Energy Ltd (KOS.N)